World’s first high accuracy blood test for Alzheimer’s Disease


World’s first high accuracy blood test for Alzheimer’s Disease

  • June 24, 2019

A research team led by iHealthtech principal investigator Asst Prof Shao Huilin has developed a new, highly accurate blood test for Alzheimer’s Disease called Amplified Plasmonic EXosome (APEX) that is faster and more cost effective than conventional tests. 

Currently, there are three ways to diagnose dementia: a neuropsychological test which is not very accurate, spinal fluid sampling which is invasive, and Positron Emission Tomography (PET) imaging which is accurate but costly. A number of blood-based tests are under development but till date have poor performance. 

“New tests that are under investigation have either poor accuracy or low sensitivity. The APEX technology addresses both of these limitations and is therefore a very powerful and objective companion diagnostic system to complement existing clinical and neuropsychological tests for early detection and better management of AD,” Asst Prof Shao said. 

The APEX test will enable early detection for Alzheimer’s Disease and offer new opportunities for intervention and management. The convenience of blood test will also allow doctors to monitor patient’s response to treatment. 

Please click the link below for the research article: 

Please click the links below for the news articles: